4AQ3

HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 0.245 
  • R-Value Work: 0.201 
  • R-Value Observed: 0.203 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history


Literature

Identification of a Phenylacylsulfonamide Series of Dual Bcl-2/Bcl-Xl Antagonists.

Perez, H.L.Banfi, P.Bertrand, J.A.Cai, Z.W.Grebinski, J.W.Kim, K.Lippy, J.Modugno, M.Naglich, J.Schmidt, R.J.Tebben, A.Vianello, P.Wei, D.D.Zhang, L.Galvani, A.Lombardo, L.J.Borzilleri, R.M.

(2012) Bioorg Med Chem Lett 22: 3946

  • DOI: 10.1016/j.bmcl.2012.04.103
  • Primary Citation of Related Structures:  
    4AQ3

  • PubMed Abstract: 
  • A series of phenylacylsulfonamides has been prepared as antagonists of Bcl-2/Bcl-xL. In addition to potent binding affinities for both Bcl-2 and Bcl-xL, these compounds were shown to induce classical markers of apoptosis in isolated mitochondria. Overall weak cellular potency was improved by the incorporation of polar functionality resulting in compounds with moderate antiproliferative activity ...

    A series of phenylacylsulfonamides has been prepared as antagonists of Bcl-2/Bcl-xL. In addition to potent binding affinities for both Bcl-2 and Bcl-xL, these compounds were shown to induce classical markers of apoptosis in isolated mitochondria. Overall weak cellular potency was improved by the incorporation of polar functionality resulting in compounds with moderate antiproliferative activity.


    Organizational Affiliation

    Bristol-Myers Squibb Research, PO Box 4000, Princeton, NJ 08543, USA. heidi.perez@bms.com



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
APOPTOSIS REGULATOR BCL-2, BCL-2-LIKE PROTEIN 1A, B, C, D, E, F169Homo sapiensMutation(s): 2 
Gene Names: BCL2L1BCL2LBCLXBCL2
UniProt & NIH Common Fund Data Resources
Find proteins for Q07817 (Homo sapiens)
Explore Q07817 
Go to UniProtKB:  Q07817
PHAROS:  Q07817
Find proteins for P10415 (Homo sapiens)
Explore P10415 
Go to UniProtKB:  P10415
PHAROS:  P10415
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
398 (Subject of Investigation/LOI)
Query on 398

Download Ideal Coordinates CCD File 
G [auth A], H [auth B], I [auth C], J [auth D], K [auth E], L [auth F]N,N-dibutyl-4-chloranyl-1-[2-(3,4-dihydro-1H-isoquinolin-2-ylcarbonyl)-4-[(7-iodanylnaphthalen-2-yl)sulfonylcarbamoyl]phenyl]-5-methyl-pyrazole-3-carboxamide
C40 H41 Cl I N5 O5 S
DKJBPPVETUSFTM-UHFFFAOYSA-N
 Ligand Interaction
Binding Affinity Annotations 
IDSourceBinding Affinity
398 PDBBind:  4AQ3 IC50: 37 (nM) from 1 assay(s)
Binding MOAD:  4AQ3 IC50: 37 (nM) from 1 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 0.245 
  • R-Value Work: 0.201 
  • R-Value Observed: 0.203 
  • Space Group: P 32
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 115.214α = 90
b = 115.214β = 90
c = 102.318γ = 120
Software Package:
Software NamePurpose
REFMACrefinement
DENZOdata reduction
SCALEPACKdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment  



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2012-06-06
    Type: Initial release
  • Version 1.1: 2012-11-21
    Changes: Database references